Kислород Siad (Oxygen)

When inhaled, oxygen diffuses across the alveolar membrane into the pulmonary capillaries, raising arterial partial pressure of oxygen. This creates a larger gradient for oxygen to move from blood into tissues, supporting cellular respiration and energy production. The increased dissolved oxygen improves overall tissue oxygenation without binding to specific receptors.

The dose of Kислород Siad is individualized by the prescribing clinician based on the patient’s oxygen saturation, underlying condition, and delivery system. The prescriber determines the flow rate, concentration, and duration of therapy to achieve target oxygen levels, and adjustments are made according to clinical response.

Limited specific data are available for Kислород Siad in pregnancy and lactation. Oxygen therapy is generally considered when the maternal benefit outweighs potential risks. Clinicians should evaluate each case, monitor maternal and fetal oxygenation closely, and follow local guidelines for use in pregnant or nursing patients.

To request Kислород Siad, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, confirming trade or institutional credentials before providing pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Kислород Siad is supplied as a high‑purity medical gas meeting EU standards, comparable to other certified oxygen cylinders. Its key differentiators are GNH India’s GDP‑compliant supply chain, consistent quality control, and global logistics support. Clinically, it provides the same therapeutic oxygen concentration as alternative medical‑grade oxygen products.

Kислород Siad cylinders should be stored at ambient temperature in a well‑ventilated, dry area away from heat sources, direct sunlight, and combustible materials. Cylinders must be secured upright, protected from physical damage, and handled only by trained personnel using appropriate regulators and delivery equipment.

Kислород Siad is administered by connecting the cylinder to a regulator and delivering the gas through a nasal cannula, simple face mask, or specialized anesthesia circuit. The prescriber sets the flow rate and concentration based on the patient’s oxygenation targets, and continuous monitoring ensures safe and effective therapy.

Serious risks include pulmonary oxygen toxicity, which can cause inflammation and edema of lung tissue after prolonged high‑concentration exposure, and central nervous system toxicity, potentially leading to seizures. Additionally, the high concentration of oxygen markedly increases fire risk; any leak near open flames or sparks can result in rapid combustion.

Kислород Siad should be avoided in patients with known hypersensitivity to oxygen delivery equipment, in environments where fire hazards cannot be controlled, and in individuals with certain conditions such as untreated severe chronic obstructive pulmonary disease with carbon dioxide retention where high‑flow oxygen may worsen hypercapnia. Clinical judgment is required for each case.